BIG Cut In Covid19 Vaccine Prices Announced
The Subject Expert Committee on COVID-19 of the Central Drugs Standard Control Organisation had on Friday recommended giving permission for conducting a phase-3 clinical trial of the single-dose COVID-19 vaccine Sputnik Light as a booster dose.
In a research note, India Ratings and Research (Ind-Ra) said it has maintained a neutral outlook for the Indian pharmaceutical sector for FY23.
Meanwhile, the doors of Srimandir have remained closed for the public since January 10. The shrine will remain shut till January 31 in view of the rising cases of Coronavirus in the State and also the detection of some cases in the shrine.
COVAXIN Booster Dose Data Shows Promising Results
Briefing reporters about the current pandemic situation in the State, Director, Family Welfare and nodal officer for Covid vaccination, Dr Bijay Panigrahi informed that the vaccination rate is low in five districts of the State, including Gajapati, Sundargarh, Cuttack, Angul and Mayurbhanj.
Will COVID19 Booster Dose Help? Health Expert Shares Views
As many 5,25,35,282 vaccine doses have been administered to the people of the State so far. While 91.6 percent have received the first dose and 68 per cent have received both doses, further informed Panigrahi.
India Announces Booster Dose For Specific Categories
India charts a separate way. Addressing the nation on Saturday, PM Narendra Modi announced that children in the 15-18 years age group will now get COVID-19 vaccines starting 3rd January 2022. The government has also decided that precaution dose of vaccine will be started for frontline workers and healthcare workers and elderly with co-morbid conditions.
Bijay Panigrahi, Director, Health and Family Welfare Department on Friday said that the government has targeted to administer first dose of Covid vaccine to all eligible beneficiaries among the target population by December this year.
Pharma major Biological E has sought approval from drug regulator Drugs Controller General of India to conduct the phase-3 clinical trial of Covid vaccine Corbevax.